NAUT - Nautilus Biotechnology GAAP EPS of -$0.11 beats by $0.03 November, 01 2022 06:18 AM Nautilus Biotechnology Inc. Nautilus Biotechnology press release ( NASDAQ: NAUT ): Q3 GAAP EPS of -$0.11 beats by $0.03 . Cash, cash equivalents, and investments were $323.6M as of September 30, 2022. For further details see: Nautilus Biotechnology GAAP EPS of -$0.11 beats by $0.03